385 related articles for article (PubMed ID: 27411432)
21. Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients.
Skärstrand H; Vaziri-Sani F; Delli AJ; Törn C; Elding Larsson H; Ivarsson S; Agardh D; Lernmark Å;
Pediatr Diabetes; 2015 Dec; 16(8):621-8. PubMed ID: 25258030
[TBL] [Abstract][Full Text] [Related]
22. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies in type 1 diabetes.
Taplin CE; Barker JM
Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
[TBL] [Abstract][Full Text] [Related]
24. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
[TBL] [Abstract][Full Text] [Related]
25. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study.
Gullstrand C; Wahlberg J; Ilonen J; Vaarala O; Ludvigsson J
Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):182-90. PubMed ID: 18331414
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
[TBL] [Abstract][Full Text] [Related]
27. Experiments by nature: lessons on type 1 diabetes.
Battaglia M
Tissue Antigens; 2014 Jan; 83(1):1-9. PubMed ID: 24355002
[TBL] [Abstract][Full Text] [Related]
28. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
[TBL] [Abstract][Full Text] [Related]
29. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
30. Genetic risk factors for type 1 diabetes.
Pociot F; Lernmark Å
Lancet; 2016 Jun; 387(10035):2331-2339. PubMed ID: 27302272
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus.
Dereke J; Nilsson C; Landin-Olsson M; Hillman M
Diabet Med; 2012 Dec; 29(12):e436-9. PubMed ID: 22924602
[TBL] [Abstract][Full Text] [Related]
32. Non-HLA gene effects on the disease process of type 1 diabetes: From HLA susceptibility to overt disease.
Lempainen J; Laine AP; Hammais A; Toppari J; Simell O; Veijola R; Knip M; Ilonen J
J Autoimmun; 2015 Jul; 61():45-53. PubMed ID: 26074154
[TBL] [Abstract][Full Text] [Related]
33. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
[TBL] [Abstract][Full Text] [Related]
34. Re-exposure to beta cell autoantigens in pancreatic allograft recipients with preexisting beta cell autoantibodies.
Mujtaba MA; Fridell J; Book B; Faiz S; Sharfuddin A; Wiebke E; Rigby M; Taber T
Clin Transplant; 2015 Nov; 29(11):991-6. PubMed ID: 26289931
[TBL] [Abstract][Full Text] [Related]
35. Role of immune system in type 1 diabetes mellitus pathogenesis.
Szablewski L
Int Immunopharmacol; 2014 Sep; 22(1):182-91. PubMed ID: 24993340
[TBL] [Abstract][Full Text] [Related]
36. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk.
Hämäläinen AM; Ronkainen MS; Akerblom HK; Knip M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4249-53. PubMed ID: 11095462
[TBL] [Abstract][Full Text] [Related]
37. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.
Wang Y; Xiao Y; Zhong L; Ye D; Zhang J; Tu Y; Bornstein SR; Zhou Z; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4239-48. PubMed ID: 25092677
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
39. Signs of beta-cell autoimmunity in nondiabetic schoolchildren: a comparison between Russian Karelia with a low incidence of type 1 diabetes and Finland with a high incidence rate.
Kondrashova A; Viskari H; Kulmala P; Romanov A; Ilonen J; Hyöty H; Knip M
Diabetes Care; 2007 Jan; 30(1):95-100. PubMed ID: 17192340
[TBL] [Abstract][Full Text] [Related]
40. Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity.
Honkanen J; Vuorela A; Muthas D; Orivuori L; Luopajärvi K; Tejesvi MVG; Lavrinienko A; Pirttilä AM; Fogarty CL; Härkönen T; Ilonen J; Ruohtula T; Knip M; Koskimäki JJ; Vaarala O
Front Immunol; 2020; 11():468. PubMed ID: 32265922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
